Clinical Trials Browser

INDUSTRY × trimebutine 3-thiocarbamoylbenzenesulfonate × Gastrointestinal × Clear all

NCT01926444 2019-05-08

A Phase 2a, Proof-of-Concept Study of GIC-1001 in the Management of Visceral Pain During Sedation-Free, Full Colonoscopy

Phase 2 Completed

308 enrolled 14 charts

Gastrointestinal

Agnosia, Colonic Diseases, Neoplasms, Pain, Colorectal Neoplasms

NCT02276768 2016-08-10

Study on Analgesia of GIC-1001 & GIC-1002 on Visceral Pain, Rectal Sensory Threshold Using the Barostat Method

Phase 1 Completed

Gastrointestinal

Agnosia, Colonic Diseases, Colonic Neoplasms, Neoplasms, Pain, Visceral Pain